Trial Profile
an fMRI study on the effects of NicVAX and placebo on Central Nervous System activation and behaviour following a nicotine challenge
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2023
Price :
$35
*
At a glance
- Drugs Nicotine abuse vaccine (Primary)
- Indications Smoking withdrawal; Substance-related disorders
- Focus Pharmacodynamics
- 10 Dec 2023 Status changed from recruiting to completed.
- 08 Jun 2011 New trial record